07.17.25 -- Navigating Allogeneic Cell Therapy Supply Chain Management

Explore data-driven advancements in cell therapy manufacturing and learn how focusing on biology first can lead to more robust and scalable manufacturing solutions.

Scaling up life-saving gene-edited cell therapies means tackling production inefficiencies. Overcoming the time-consuming and risky cell washing step is crucial for clinical and commercial success.

Explore a scalable protocol for T cell activation and expansion, designed to enhance immunotherapy workflows. This approach ensures robust T cell growth, viability, and memory phenotypes. 

Electroporation enables genetic research by introducing material into cells, advancing disease modeling, gene therapy, and ion channel studies.

As the cell therapy industry experiences rapid growth, media and reagents present a valuable opportunity to meet future therapeutic needs.

Explore key considerations for manufacturing RNA-LNP drug products surrounding process and analytical development, automation, environmental monitoring, and strategic collaborations.

Learn more about modular, fit-for-purpose platforms designed specifically to meet the requirements of cell therapy manufacturing right now, and in the future.

Single-use strategies and tools are constantly evolving to better serve industry needs, and adept solutions providers can help streamline development with simple, custom adaptations.

We review the pre-use post sterilization integrity testing process and how its compatibility with single-use technology offers advantages compared to stainless-steel systems.